Clinical trials recruiting for Pancreatic Ductal Adenocarcinoma (mPDAC)
3
Recruiting trials
1
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Cemiplimab Plus Gemcitabine | 1 |
| DA-3501 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
Top cities
Self-screener
Recruiting trials
- A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma
- Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
- Immunoparalysis After Pancreaticoduodenectomy
Related conditions
Trials recruiting for Pancreatic Ductal Adenocarcinoma (mPDAC) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Pancreatic Ductal Adenocarcinoma (mPDAC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.